Navigation Links
New Roche Dual Target HIV-1 Test Approved for Use in European Union
Date:12/15/2008

stics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at http://www.roche.com.

All trademarks used or mentioned in this release are legally protected by law.

     For further information please contact:
     Jessica E. Brillant
     Molecular Diagnostics Communications
     925.730.8503

    (1) World Health Organization. http://www.who.int

'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Improved Testing for Hepatitis B Virus From Roche
2. Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
3. Roche Holds Sixth Annual Childrens Walk in Nutley
4. New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
5. Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales
6. Primary Insomnia Tied to Brain Neurochemical Imbalance
7. Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults
8. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
9. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
10. Genentech/Roche/Chugais Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
11. Balloon Manor Reappears in Rochester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Somerset, N.J. (PRWEB) September 30, 2014 ... global provider of advanced delivery technologies and development ... today announced a full agenda for the 25th ... Paris, France, from October 6th to 9th. , ... and supply capability expansions during the show, including ...
(Date:9/30/2014)... its latest blog post, Best Drug Rehabilitation , which ... during a stay in rehab can make a big difference ... on 5 reasons why relapse shouldn’t stand in the way ... a one-time event, like reaching the finish line of a ... “It’s an ongoing process and a lifelong commitment that will ...
(Date:9/30/2014)... devised a way to rapidly test hundreds of different ... discover promising new ways to deliver a class of ... DNA, to human patients. , In a study appearing ... used this technology to identify materials that can efficiently ... type of high-speed screen could help overcome one of ...
(Date:9/30/2014)... cells cannot multiply and cardiac muscles contain few ... itself after a heart attack. Now Tel Aviv ... standard in cardiac tissue engineering. , Dr. Tal ... TAU,s Department of Biotechnology, Department of Materials Science ... have been developing sophisticated micro- and nanotechnological tools ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 RISC ... IT Infrastructure analytics across data center, cloud and ... achieved an important milestone of helping more than ... for important projects such as IT infrastructure transformation, ... , The strong customer engagement rates and partner ...
Breaking Medicine News(10 mins):Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 2Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 3Health News:High-speed drug screen 2Health News:High-speed drug screen 3Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 3
... methodology behind WHO rankings, WASHINGTON, Feb. 26 ... in what could be,the final debate before the nominee ... be a topic of discussion. But as the two ... tales of people (invariably,swing state residents) encountered on the ...
... YORK (Feb. 26, 2008) -- As many as ... not respond to the standard first-line chemotherapy placed ... data. When this happens, typically, their only option ... at the Herbert Irving Comprehensive Cancer Center of ...
... Feb. 26 ULLICO Casualty Group (ULLICO,Casualty) has ... fiduciary and union liability insurance programs. Hudson is ... than $2,billion) by A.M. Best Company. Hudson is ... the holding company for one of the world,s,largest ...
... provoked soil-dwelling bacteria into producing a new type of ... in a battle for survival. , The antibiotic holds ... ulcers in humans. Also, figuring out the still murky ... help scientists develop strategies for finding other new antibiotics. ...
... Board: HFIT), a leading employee health improvement company,will report ... 31, 2007, on Wednesday, March 5, 2008, after the ... a conference call to discuss the,results the same day. ... and chief executive officer, and Wes Winnekins, chief financial,officer., ...
... 26 At Beverly Hills,Liposculpture, Dr. Alan Bittner ... safe breast reduction surgery that can reduce,breasts by ... The procedure,called liposculpture breast reduction, takes approximately 90 ... fat (more than 3 coke cans!) from each ...
Cached Medicine News:Health News:World Health Report Rankings Driven by Ideology, Skewed Data 2Health News:Study looks at new bladder cancer therapy for patients unresponsive to standard treatment 2Health News:ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance 2Health News:ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance 3Health News:Bacterial 'battle for survival' leads to new antibiotic 2Health News:Bacterial 'battle for survival' leads to new antibiotic 3Health News:Health Fitness Corp. to Report Fourth Quarter and Year End 2007 Financial Results on March 5, 2008 2Health News:Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50% 2Health News:Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50% 3
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 ... agreement that allows Kessler Foundation and New Jersey ... biomedical research, education and patient care programs has ... and chief executive officer of Kessler Foundation and ... Jersey Health Foundation. "The experience of ...
(Date:9/30/2014)... , Sept. 30, 2014  Based on ... market, Frost & Sullivan recognizes Ventana Medical Systems, ... with the 2014 North American Frost & Sullivan ... quality practices along with a focus on innovation ... global leader in tissue-based cancer diagnostic solutions for ...
(Date:9/30/2014)... YORK , Sept. 30, 2014  Proteomics ... according to a new report from Kalorama Information.  The ... deals had occurred in proteomics in the past ... IPOs, to agreements between private proteomic companies and ... companies with novel proteomics innovator companies.  Kalorama observed ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
... Aug. 23 /PRNewswire-FirstCall/ -- Today at ... FUJIFILM Medical Systems U.S.A., Inc. announced that it ... D-EVO™ flat panel detector.  As U.S. installations of ... departments will begin benefiting from the seamless transition ...
... today announced that it has signed an exclusive agreement ... tablets) 10 mcg.  Under the terms of the agreement, ... in the U.S. beginning August 2 through the company,s ... Vagifem® 10 mcg to the U.S. market earlier this ...
Cached Medicine Technology:FUJIFILM's FDR D-EVO™ is Now Available and Shipping 2Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg 2Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg 3
Inquire...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of...
Medicine Products: